Among the categories of investors, non-institutional investors (NIIs) led the demand for the public offering, oversubscribing their reserved portion by 21.95 times
Once the basis of allotment is finalised, investors who have applied for the public offering can check the Defrail Technologies IPO allotment status on official websites of BSE, Maashitla Securities
Gabion Technologies shares started their maiden trading session at ₹89 per share on the BSE SME, against the issue price of ₹81 per share, reflecting a premium of ₹8 per share or 9.88 per cent
Amagi Media Labs is set to launch a ₹1,788.62 crore IPO on Tuesday, January 13, 2026, while Bharat Coking Coal will make its market debut on January 16
Once basis of allotment is finalised, investors who have applied for the public offering can check the Gabion Technologies IPO allotment status on the official websites of BSE and Kfin Technologies
The positive sentiment surrounding the IPO is also reflected in the grey market, where unlisted shares of Gabion Technologies are reportedly trading at a solid premium
Sai Urja Indo IPO will consist of a fresh issuance of 3,066,000 equity shares, and an offer for sale by promoters Santosh Ajay Kumar Mittal and Harsh Ajaykumar Mittal, divesting up to 312,000 shares
Modern Diagnostic started its maiden trading session at ₹99.50 per share on the BSE SME, reflecting a premium of ₹9.50 or 10.56 per cent over the IPO issue price of ₹90 per share
Stock Market LIVE Updates, Monday, December 29, 2025: In broader markets, the Nifty Midcap was down 0.05 per cent, while the Nifty Smallcap index was lower by 0.06 per cent
Modern Diagnostic & Research Centre will launch its IPO on Wednesday, December 31, 2025, while multiple SME listings, including EPW India and Dachepalli Publishers, are slated for next week
Stock Market Close Highlights, Monday, December 22, 2025: On BSE, Trent, Infosys and Bharti Airtel were top gainers, while SBI, Kotak Mahindra and Larsen and Toubro (L&T) were the top drags.
IPO Calendar: Nephrocare, Park Medi World, Wakefit Innovations, and Corona Remedies, are set to open for subscription, aiming to raise a combined ₹3,735 crore